Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immediate versus deferred treatment for advanced disease

D Kirk1

  • 1Department of Urology, Western Infirmary, Glasgow.

Cancer Surveys
|January 1, 1995
PubMed
Summary

For men with early prostate cancer, deferring hormonal treatment may not compromise survival. Immediate treatment benefits are not yet clearly demonstrated, making deferred therapy a valid option with careful monitoring.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetically localized and wash-free fluorescent immuno-assay: From a research platform (MLFIA) to a multiplexed POC system (MagIA).

SLAS technology·2024
Same author

Magnetically localized and wash-free fluorescence immunoassay (MLFIA): proof of concept and clinical applications.

Lab on a chip·2023
Same author

Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitis.

Alimentary pharmacology & therapeutics·2018
Same author

Effects of prepartum dietary cation-anion difference on aspects of peripartum mineral and energy metabolism and performance of multiparous Holstein cows.

Journal of dairy science·2017
Same author

"Is TGfU a Model Only Test Pilots Can Fly?": Teacher-Coach Development in Game-Centered Approaches.

Research quarterly for exercise and sport·2016
Same author

A Method for Investigating "Instructional Familiarity" and Discerning Authentic Learning.

Annals of medical and health sciences research·2016

Area of Science:

  • Oncology
  • Urology
  • Clinical Trials

Background:

  • The optimal timing for initiating hormonal therapy in prostate cancer management remains a long-standing debate.
  • Early studies (VACURG) indicated that delaying treatment in asymptomatic patients might not negatively impact survival.
  • Recent research on maximal androgen blockade suggests earlier disease presentation could correlate with higher hormone sensitivity.

Purpose of the Study:

  • To evaluate the survival outcomes associated with immediate versus deferred hormonal treatment for prostate cancer.
  • To weigh the benefits of early intervention against potential side effects and costs.
  • To provide evidence-based guidance on prostate cancer treatment timing.

Main Methods:

  • Recruitment of 1938 patients for a Medical Research Council (MRC) study on treatment timing.
  • Analysis of survival data comparing immediate hormonal therapy with deferred approaches.
  • Consideration of disease presentation, hormone sensitivity, and patient-reported outcomes.

Main Results:

  • A clear survival advantage for immediate hormonal treatment has not yet been definitively established.
  • Deferred treatment is presented as a viable management strategy for many men.
  • The study emphasizes the need for careful patient selection and close follow-up for deferred treatment.

Conclusions:

  • Deferred hormonal treatment is a valid management option for prostate cancer in the absence of proven survival benefits from immediate treatment.
  • Careful monitoring and cautious application are essential when opting for deferred therapy.
  • Further results from ongoing large-scale studies are anticipated to clarify the long-term implications.

Related Experiment Videos